Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.

Dupilumab, a biologic drug approved for the treatment of moderate‐to‐severe atopic dermatitis, has been associated with resolution or improvement in pre‐existing alopecia areata. We report a case of significant improvement of AA after Dupilumab‐onset treatment for atopic dermatitis and review the literature. [ABSTRACT FROM AUTHOR]